Package Insert: Information for the Patient
Eplerenone50 mg Film-Coated Tablets
Read this package insert carefully before starting to take this medication, as it contains important information for you.
1. What is Eplerenone Pensa and for what it is used
2. What you need to know before starting to take Eplerenone Pensa
3. How to take Eplerenone Pensa
4. Possible adverse effects
5. Storage of Eplerenone Pensa
6. Contents of the package and additional information
EplerenonaPensabelongs to a group of medications known as selective aldosterone blockers. These blockers inhibit the action of aldosterone, a substance produced by the body that controls blood pressure and cardiac function. Elevated levels of aldosterone can produce changes in the body that lead to heart failure.
EplerenonaPensais used to treat heart failure to prevent worsening and reduce hospitalization if you have:
Do not take EplerenonaThink
Warnings and precautions
Consult your doctor or pharmacist before starting to take eplerenona:
Use of EplerenonaThinkwith other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
Eplerenona may affect other medications. These, in turn, may affect the proper functioning of eplerenona.
Do not take EplerenonaThinkwith the following medications (see section "Do not use EplerenonaThink”):
Inform your doctor if you are taking any of the following medications:
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Taking EplerenonaThinkwith food and drinks
EplerenonaThinkcan be taken with or without food.
Pregnancy and breastfeeding
The effect ofEplerenonaon humans during pregnancy has not been evaluated.Eplerenonais unknown whether eplerenona is excreted in breast milk. Your doctor will decide with you whether to stop breastfeeding or suspend treatment.
If you are pregnant or breastfeeding, or if you think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
After takingEplerenonaThink, you may feel dizzy. If this happens, do not drive or operate machinery.
EplerenonaThinkcontains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions for Eplerenona as indicated by your doctor. Consult your doctor or pharmacist again if you have any doubts.
The Eplerenona Pensa tablets can be taken with or without food. Swallow the tablets whole with plenty of water.
Eplerenona Pensa is usually taken together with other medications for heart failure, such as beta-blockers. The usual initial dose is one 25 mg tablet once a day, increasing after 4 weeks to 50 mg daily (one 50 mg tablet or two 25 mg tablets). The maximum dosage regimen is 50 mg per day.
It is necessary to measure blood potassium levels before starting treatment with Eplerenona Pensa, during the first week, and one month after starting treatment or after a change in dosage. Your doctor may adjust the dose based on your blood potassium levels.
If you have mild kidney failure, you should start treatment with one 25 mg tablet per day, and if you have moderate kidney failure, you should start treatment with one 25 mg tablet every other day. These doses may be adjusted, if your doctor indicates, and in accordance with your blood potassium levels.
Eplerenona Pensa is not recommended for patients with severe kidney disease.
No initial dose adjustment is required in patients with mild to moderate liver insufficiency. If you have liver or kidney problems, you may need to have your blood potassium levels checked more frequently (see also “Do not take Eplerenona Pensa”).
In the elderly: no initial dose adjustment is required.
In children and adolescents: Eplerenona Pensa is not recommended.
If you take more Eplerenona Pensa than you should
If you take more Eplerenona Pensa than you should, inform your doctor or pharmacist immediately. If you have taken too much medication, the most likely symptoms will be low blood pressure (manifested as dizziness, blurred vision, weakness, acute loss of consciousness) or hyperkalemia, high levels of potassium in the blood (manifested by muscle cramps, diarrhea, nausea, dizziness, or headache).
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Eplerenona Pensa
If it is almost time to take the next tablet, skip the dose you forgot and take the next tablet at the usual time.
Otherwise, take the tablet as soon as you remember, as long as more than 12 hours have passed since the usual time for taking the next tablet. Then, resume your medication as usual. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Eplerenona Pensa
It is essential to continue taking Eplerenona Pensa as instructed, unless your doctor tells you to stop treatment. If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications,EplerenonaPensamay cause side effects, although not everyone will experience them.
If any of the following occur:
Seek immediate medical attention
These are symptoms of angioneurotic edema.
Other side effects reported include:
Common side effects(occur in 1 to 10 of every 100 patients):
Rare side effects(occur in 1 to 10 of every 1,000 patients):
If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this prospectus.
Keep this medication out of the sight and reach of children.
Do not useEplerenonaPensaafter the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of through drains or in the trash. Deposit the packaging and unused medicines at the SIGRE collection point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.
Eplerenone CompositionPensa
Opadry II. white OY-L-28900: lactose monohydrate, hypromellose (Type 2910), titanium dioxide (E171), macrogol 4000 (tablet coating).
Appearance of the product and contents of the packaging
50 mg tablet: white to off-white coated tablets, round, biconvex, marked “CG4” on one face of the tablet and smooth (unmarked) on the other face.
EplerenonePensa50 mg coated tablets are available in blister packs of 30 and 50 tablets.
Marketing Authorization Holder and Responsible Manufacturer
Marketing Authorization Holder:
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Responsible Manufacturer:
Laboratorios Liconsa S.A.
Avenida Miralcampo 7, Industrial Estate Miralcampo
19200 Azuqueca de Henares, Guadalajara
Spain
Last review date of this leaflet:August 2012
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.